Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

Commercial Jobs in Biotech & Pharma | Formulate

Commercial Jobs

8,535 open commercial positions

Research & Development Clinical Development Clinical Operations Regulatory Affairs Quality Assurance Manufacturing Medical Affairs Business Development

Pediatric Office Sales Specialist - San Francisco, CA

Abbott

Posted 3w ago

Remote

$61K - $123K

Full-time

Remote

Commercial

Neurology

MID

H-1B · 1 FY23

Service Sales Leader

GE HealthCare

Posted 3w ago

AUS08-01-Sydney-241 O'Riordan Street, 8F

Full-time

CommercialNeurologyMID

Service Imaging Product Leader - ANZ

GE HealthCare

Posted 3w ago

AUS08-01-Sydney-241 O'Riordan Street, 8F; AUS10-01-Melbourne-290 Burwood Rd; AUS11-01-Brisbane-520 Wickham St

Full-time

CommercialMID

Ultrasound Applications & Sales Specialist

GE HealthCare

Posted 3w ago

Remote

Full-time

RemoteCommercialGastroenterologyMID

Werkstudent im Marketing (m/w/d)

Abbott

Posted 3w ago

Germany - Wiesbaden-Delkenheim

Full-time

Condition in scope: Diabetes Mellitus

CommercialNeurologyMID

H-1B · 1 FY23

Sales Force Excellence Manager (m/f/d)

Abbott

Posted 3w ago

Germany - Wiesbaden-Delkenheim

Full-time

CommercialNeurologyMANAGER

H-1B · 1 FY23

Senior Director, Head Launch Excellence

Amgen

Posted 3w ago

Portugal - Lisbon (Flex Commuter / Hybrid)

Full-time

CommercialExecutive

H-1B · 3 FY23

Account Manager/Specialty Account Manager- TAVNEOS - Los Angeles, CA

Amgen

Posted 3w ago

California - Los Angeles, US (Field Worker)

$145K - $197K

Full-time

Related drug: TAVNEOS

CommercialOncologyMANAGER

H-1B · 3 FY23

Technician II - Commercial and Regulated Products, Mon - Thurs - 9:00am - 8:00pm

Molecular Devices

Posted 3w ago

Coralville, Iowa, United States

Full-time

CommercialOncologyMID

H-1B · 1 FY23

Associate Director, Neuroscience Marketing, Movement Disorders

Ipsen

Posted 3w ago

Cambridge (US)

$160K - $240K

Full-time

Related drug: DYSPORT Related drug: BOTOX Related drug: BOTOX COSMETIC

CommercialNeurologyExecutive

H-1B · 1 FY23

Commercial Lead (Rare Disease)

Ipsen

Posted 3w ago

Taipei

Full-time

CommercialRare DiseaseSenior

H-1B · 1 FY23

Automation Chemistry & Immunoassay Sales Executive (ACISE) Rocky Mountains

Siemens Healthineers

Posted 3w ago

Remote

$107K - $147K

Full-time

RemoteCommercialInfectious DiseasesExecutive

H-1B · 1 FY23

Associate Director, Customer Insights - Oncology

Regeneron

Posted 3w ago

SLEEPY HOLLOW

$157K - $257K

Full-time

CommercialOncologyExecutive

H-1B · 1 FY23

E-commerce Operation Specialist

ResMed

Posted 3w ago

CN Hangzhou

Full-time

CommercialNeurologyMID

H-1B · 2 FY23

Sales, Territory Manager - Peripheral Image Guided Therapy Devices (Central New Jersey)

Philips

Posted 3w ago

Princeton, New Jersey, United States; New Brunswick, New Jersey, United States; Morristown, New Jersey, United States

$195K - $305K

Full-time

CommercialMANAGER

Sales, Key Account Manager - Mobile Surgery (South Florida)

Philips

Posted 3w ago

Miami, Florida, United States; Ft. Lauderdale, Florida, United States

$179K - $215K

Full-time

CommercialCardiologyMANAGER

Key Account Manager

Molecular Devices

Posted 3w ago

Philadelphia, Pennsylvania, United States

$108K - $113K

Full-time

CommercialMANAGER

H-1B · 1 FY23

Sales Representative - South Bend, IN - Sports Medicine

Stryker

Posted 3w ago

South Bend, Indiana

$69K - $166K

Full-time

CommercialNeurologyMID

H-1B · 3 FY23

Manager, Commercial Analytics - (Hybrid - Acton, MA)

Insulet

Posted 3w ago

Massachusetts, US (Hybrid)

Full-time

CommercialEndocrinologyMANAGER

H-1B · 10 FY23

Associate Marketing Specialist BE/NL

Insulet

Posted 3w ago

Netherlands, NL (Hybrid)

Full-time

Condition in scope: Diabetes Mellitus

CommercialMetabolic DiseasesEntry

H-1B · 10 FY23

Previous
1
190
191
192
427
Next